• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Study: RhinAer Treatment Improves Chronic Rhinitis Symptoms

    CE Mark Granted for IVF Decision Support Tool

    FDA Approves Full-Body MRI Compatibility With Inspire Therapy

    Edwards' PASCAL Precision Gains EU Nod

    Monkeypox Outbreak Driving New IVD Device Development
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    BMP Medical

    Xact Wire EDM Corp.

    JBC Technologies

    Cirtec Medical

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Buyer and Seller Tips on Mergers & Acquisitions for MPO Companies

    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    BMP Medical

    Xact Wire EDM Corp.

    JBC Technologies

    Cirtec Medical

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    CE Mark Granted to Expandable, Biodegradable Biliary Stent

    The UNITY-B Percutaneous Balloon Expandable Biodegradable Biliary Stent is intended to facilitate the drainage of obstructed ducts requiring larger openings.

    Related CONTENT
    • BMP Medical - Delivering Custom Plastics Manufactured Solutions
    • Teleflex Medical OEM
    • Hermetic Solutions Group
    • P1 Technologies
    • IBC Coatings Technologies
    PR Newswire09.07.21
    QualiMed Innovative Medizinprodukte GmbH, a wholly owned subsidiary of Dublin, Ireland-based Q3 Medical Devices Limited (Q3), has received CE mark approval for a dedicated percutaneous biodegradable metal alloy based stent implant for biliary applications, the UNITY-B Percutaneous Balloon Expandable Biodegradable Biliary Stent (BEBS).
     
    The UNITY-B Percutaneous BEBS was developed for the percutaneous treatment of hepatobiliary obstruction requiring large opening drainage with the added benefit of eliminating removal procedures associated with traditional non-degradable implants. Before the recent introductions of biodegradable biliary and pancreatic drainage devices, biliary and pancreatic duct implants were made of non-degrading plastics or metals. These traditional plastic and metal implants typically require multiple procedures to place the stents, treat associated complications, and remove the implants as their removal is mandatory in most cases. The removal requirement associated with the traditional implants has the effect of doubling the total cost of care by requiring two operations (one for the device implant and one for the device removal) versus one operation (one for the device implant) for the biodegradable devices. Biodegradable devices have the added benefit of dissolving in the body after they have completed their work.

    "The CE mark approval of the UNITY-B Percutaneous Biodegradable implant represents yet another milestone for QualiMed and all the companies of Q3 Medical and our collective mission of Creating Value By Helping People. In these uncertain times, being able to provide total cost of care cost-saving using advanced, clinically proven products is more important than ever," said Eric K. Mangiardi, CEO of Q3. "As we continue the development of additional biodegradable technologies to expand our portfolio for use in the gastrointestinal tract and peripheral vasculature, we are striving to shift the paradigm for treatments by reducing complications and eliminating the need for additional removal procedures or latent complications associated with the current treatment options." 
     
    The UNITY-B biodegradable stent is a large diameter balloon expandable biodegradable implant that is introduced percutaneously and is intended to facilitate the drainage of obstructed ducts requiring larger openings. The UNITY-B biodegradable stent is designed to replace the estimated 1 billion euros-plus global market for non-degradable metal biliary implants. The UNITY-B biodegradable percutaneous stent was developed as an alternative to avoid the second removal procedures required with the traditional covered and uncovered metallic stents. The QualiMed percutaneous biodegradable balloon expandable implant provides an advanced treatment option to the traditional plastic and metallic implants used by gastroenterologists, surgeons, and interventional radiologists to reduce the total cost of care and complications associated with the older generation of non-biodegradable plastic and metallic implants. 
     
    The UNITY-B Biodegradable Stent is designed based on the functionality of the musculoskeletal system where the biodegradable magnesium alloy mimics the bone and the polymer acts more like the muscle. The skeletal (magnesium) portion of the system serves as the main support structure. The muscle (polymer) helps to support movement and stability eliminating the short comings found in first-generation biodegradable technology. 

    "This device opens a new era in biodegradable advancements that are easy to use and similar to the current technology so no additional training is needed. The technology also has the additional benefit of potentially eliminating the second procedure required for stent removal with the traditional technology and eliminating the cost of care for the patients and the insurance providers. With its reliable degradation profile, ease of use, and cost saving benefits the device will surely see utility in other applications throughout the gastrointestinal and peripheral vasculature," said professor of Radiology Gianpaolo Carrafiello, from the University of Milano in Milano, Italy.
     
    In a recent safety and efficacy clinical study conducted, the UNITY-B biodegradable system showed no adverse events and no serious adverse events reported as related or even possibly related to the UNITY-B study device. The final clinical success evaluation resulted to a success rate of 94.4 percent, which is outstanding in comparison to the ESGE 2012 guideline for traditional products, which just for stent dysfunction already reports 41 percent, 27 percent, and 20 percent failure rate for plastic stents, uncovered SEMS (self-expandable metallic stents) and covered SEMS, respectively.
     
    Doctor Pérez-Cuadrado-Robles, an interventionalist stated, "The UNITY-B Biodegradable Stent will become a new paradigm in the management of pancreatobiliary diseases. Patients with a variety of indications, such as benign biliary strictures, biliary stones, prevention of post-sphincterotomy bleeding, biliary leaks etc. can be candidates to this technology. Indeed, this intuitive and outstanding stent can prevent second-look procedures and their procedure-related complications, resulting in a cost-effective and safe approach. Notably, the UNITY-B has major advantages in patients with a difficult access to the biliary duct (i.e., surgical anatomy). For all these reasons, this new technology should be an integral part in the management of pancreatobiliary diseases armamentarium."
     
    It is an exciting time for the company stated Eric Mangiardi, CEO of Q3 Medical as "this is only the beginning of the creative journey developing biodegradable implants for use by interventionalists and surgeons in the gastrointestinal tract as a first step and in the vasculature as a second step. The company plans to continue its development for a variety of vascular indications including the commercialization of a specialty biodegradable implants for vascular dissections and occlusions including biodegradable covered versions of the UNITY Platform. To date, Q3 Medical through its portfolio companies like QualiMed, AMG, Qsan, and QualiMed USA, has five differentiated biodegradableproducts CE approved for treatment of a wide range of gastrointestinal indications in the hepatobiliary tract. The companies are focused on additional developments to expand the biodegradable product offering in the gastrointestinal and peripheral vascular areas."
     
    QualiMed was founded in 1997 as an OEM manufacturer for implantable medical devices with a focus on the development and regulatory approval of coronary stents and their respective delivery devices. Later the business was expanded to peripheral vascular and non-vascular implants. Recently QualiMed has begun developing various biodegradable technologies, drug device combination products, and micro-intervention implants as part of its diversification and competitiveness strategy.
     
    To date QualiMed has obtained CE approvals for more than 70 different products. QualiMed has developed more than four drug-eluting stents, of which it has two CE mark approvals utilizing biostable polymers and one more based on proprietary, fast-degrading, biodegradable polymer coatings entering the commercialization phase.
     
    Manufacturing is organized outside of Hamburg, Germany, in the town of Winsen, where QualiMed runs two Class 10,000 cleanrooms according to EEC GMP standards. The company has production capabilities for stents, catheters, drug device combination products, and biodegradable technologies for a variety of interventional and surgical applications.
     
    Q3 Medical Devices Ltd. is an Ireland based holding company with multiple global operations in Germany, China, and the United States along with strong global partnerships and an ever growing strategic investor base. The holding and its companies develop, manufacture, and distribute bioresorbable, micro invasive, localized intraluminal drug delivery, and core products platforms for interventional cardiology, peripheral vascular, and non-vascular diseases.
     
    Q3 Medical Devices Ltd. was formed by a global group of entrepreneurs, manufactures, industry doctors, and investors, focused on the development and acquisition of medical device businesses with annual revenues between $1 million and $10 million. The acquisitions are targeted in areas that expand the groups manufacturing base and capabilities, grow its distribution channel, and accelerate its products offering, focusing on the minimally invasive treatment of patients with cardiology, peripheral vascular and non-vascular diseases.
     
     
    Suggested For You
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    Teleflex Medical OEM Teleflex Medical OEM
    Hermetic Solutions Group Hermetic Solutions Group
    P1 Technologies P1 Technologies
    IBC Coatings Technologies IBC Coatings Technologies
    Simbex Simbex
    MICRO MICRO
    DDL Inc. DDL Inc.
    High Tech Turning Co. Inc. High Tech Turning Co. Inc.
    Nissha Medical Technologies Nissha Medical Technologies
    sfm medical devices GmbH sfm medical devices GmbH
    Anjon Medical Technologies Anjon Medical Technologies
    Brosseau Consulting LLC Brosseau Consulting LLC
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Turner Imaging Systems Announces International Expansion Turner Imaging Systems Announces International Expansion

    Related Videos

    • BMP Medical - Delivering Custom Plastics Manufactured Solutions

      BMP Medical - Delivering Custom Plastics Manufactured Solutions

      Medical Contract Manufacturing, Design, Assembly & Packaging

    • Teleflex Medical OEM

      Teleflex Medical OEM

      Teleflex Medical OEM is a global business dedicated to transforming ideas into market-ready products.
      Krista Ray, Manager of Global Marketing Communications - OEM 11.30.21

    • Hermetic Solutions Group

      Hermetic Solutions Group

      ...
      Meghan Yemola, Hermetic Solutions Group 11.30.21


    • P1 Technologies

      P1 Technologies

      ...
      lydia payne, marketing communications manager 11.18.21

    • IBC Coatings Technologies

      ...
      Tony Schrank, Business Development Manager 11.16.21

    Loading, Please Wait..

    Breaking News
    • Study: RhinAer Treatment Improves Chronic Rhinitis Symptoms
    • CE Mark Granted for IVF Decision Support Tool
    • FDA Approves Full-Body MRI Compatibility With Inspire Therapy
    • Edwards' PASCAL Precision Gains EU Nod
    • Monkeypox Outbreak Driving New IVD Device Development
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT to Supply Traceable, Standardized Organic Elderberry Extract
    Herbalist and Alchemist Celebrates 40th Anniversary, Announces Expansion
    BASF Venture Capital and Aqua-Spark invest in Sea6 Energy
    Coatings World

    Latest Breaking News From Coatings World

    PPG Appoints Brad Budde Vice President and Chief Digital Officer
    AkzoNobel Creates Bespoke Colors for Volotea’s 10th Anniversary Livery
    Axalta: Red Continues as Most Preferred Car Color of Consumers in Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Study: RhinAer Treatment Improves Chronic Rhinitis Symptoms
    CE Mark Granted for IVF Decision Support Tool
    FDA Approves Full-Body MRI Compatibility With Inspire Therapy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Octapharma Adopts Automated Application System from Schreiner MediPharm
    Rentschler Biopharma Appoints Mark Caswell as VP, Site Head
    Cellipont Unveils Plans for Cell Therapy Facility in Houston
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Estée Lauder Companies Delivers Strong Results in Fiscal 2022
    Fastest-Growing Consumer Product Companies in the U.S.
    Winky Lux is Among the Top 20 Fastest-Growing Beauty Companies
    Happi

    Latest Breaking News From Happi

    Fenty Beauty Introduces Eaze Drop’lit All-Over Glow Enhancer Makeup
    EPA Calls for Nominations for 2023 Green Chemistry Challenge Awards
    Strands Hair Care Introduces The Hair Lab
    Ink World

    Latest Breaking News From Ink World

    Flint Group to Highlight AQUACode Inks, Xiekon IDERA at Corrugated Week 2022
    DuPont Selects 2022 Lavoisier and Pedersen Award Medalists
    Chemours Begins Commissioning Newest Sand Mine in Clay County, FL
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Techkon USA announces latest handheld spectrodensitometer
    Maxcess China now manufacturing solid dies in Huzhou
    Avery Dennison debuts new adhesive for wine and spirits
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    INDA Appoints Director of Membership and Industry Relations
    Nexwear Acquires Incontinence Products Brand Lily Bird
    Because Market Expands into Retail Stores
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Clears Accelus' Toro-L Interbody Fusion System
    FDA OKs VySpine's VyPlate Anterior Cervical Plates
    Moximed Raises $40M for Knee OA Shock Absorber Implant
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    ORNL Celebrates Launch of Frontier, the World’s Fastest Supercomputer
    DuPont Names 2022 Lavoisier and Pedersen Award Medalists
    Photonic Glasses Give Solar Panels Pleasing Colors

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login